b'Flow CytometryTest NameAML MRD Assay by MFCIndications for TestingAssay Type Identify tumor-specific markers forpost-treatment monitoringMultiparametric Flow Cytometry (12-color)Monitor response to therapy CAP/CLIA-validated Monitor and evaluate for disease relapseand recurrenceMethod Description12 color Multiparametric Flow Cytometry with a sensitivity of 1x10 -4 .Interpretation TurnaroundSpecimenShippingSpecimen Time Requirements Conditions Stability An interpretive24-48 hours3-5 mL of bone marrow inAmbient or Cool; Specimens report will indicateEDTA or Sodium Heparin Do not freezeshould be stored the presence/ at 2-8C and absence of AMLmust be received cell populations,by the lab within level of detection48 hours after in relation to thedrawclinical cutoff, percent and number of aberrant myeloblasts and their associated immunophenotypic profile.LabPMM Services Catalog 2021|61'